Control of bioamine metabolism by 5-HT2B and α1D autoreceptors through reactive oxygen species and tumor necrosis factor-α signaling in neuronal cells

Annals of the New York Academy of Sciences

Volumn 1091, Issue , 2006, Pages 123-141

  Schneider, Benoit ^a   Pietri, Mathéa ^a   Mouillet Richard, Sophie ^a   Ermonval, Myriam ^a   Mutel, Vincent ^b   Launay, Jean Marie ^c   Kellermann, Odile ^a  

^a INSTITUT ANDRÉ LWOFF   (France)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Autoreceptor signaling; Bioamine metabolism; Neuronal differentiation; Reactive oxygen species; TNF

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALPHA 1D ADRENERGIC RECEPTOR; ARACHIDONIC ACID; DISINTEGRIN; METALLOPROTEINASE; NEUROTRANSMITTER; NORADRENALIN; PHOSPHOLIPASE A2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SEROTONIN; SEROTONIN 2B RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ADRENERGIC RECEPTOR ALPHA(1D); ALPHA 1 ADRENERGIC RECEPTOR; BIOGENIC AMINE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; ENZYME ACTIVATION; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROECTODERM; NORADRENERGIC NERVE; OXIDATIVE STRESS; PHENOTYPE; SEROTONINERGIC NERVE CELL; STIMULATION; SYNTHESIS; ANIMAL; ARTICLE; CELL LINE; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BIOGENIC AMINES; CELL LINE; METHOXYHYDROXYPHENYLGLYCOL; MICE; NEURONS; REACTIVE OXYGEN SPECIES; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTORS, ADRENERGIC, ALPHA-1; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947596291     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1378.061     Document Type: Conference Paper

References (47)

1. GORIDIS, C. & H. ROHRER. 2002. Specification of catecholaminergic and serotonergic neurons. Nat. Rev. Neurosci. 3: 531-541.
2. GASPAR, P., O. CASES & L. MAROTEAUX. 2003. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 4: 1002-1012.
3. HOYER, D., J.P. HANNON & G.R. MARTIN. 2002. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71: 533-554.
4. PHILIPP, M. & L. HEIN. 2004. Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. Pharmacol. Ther. 101: 65-74.
5. MOUILLET-RICHARD, S., V. MUTEL, S. LORIC, et al. 2000. Regulation by neurotransmitter receptors of serotonergic or catecholaminergic neuronal cell differentiation. J. Biol. Chem. 275: 9186-9192.
6. KELLERMANN, O., S. LORIC, L. MAROTEAUX & J.M.LAUNAY. 1996. Sequential onset of three 5-HT receptors during the 5-hydroxytryptaminergic differentiation of the murine 1C11 cell line. Br. J. Pharmacol. 118(5): 1161-1170.
7. TOURNOIS, C., V. MUTEL, P. MANIVET, et al. 1998. Crosstalk between 5-HT receptors in a serotonergic cell line: involvement of arachidonic acid metabolism. J. Biol. Chem. 273: 17498-17503.
8. MANIVET, P., S. MOUILLET-RICHARD, J. CALLEBERT, et al. 2000. PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor. J. Biol. Chem. 275: 9324-9331.
9. PIETRI, M., B. SCHNEIDER, S. MOUILLET- RICHARD, et al. 2005. Reactive oxygen species-dependent TNF-alpha converting enzyme activation through stimulation of 5-HT2B and alpha1D autoreceptors in neuronal cells. FASEB J. 19: 1078-1087.
10. PORTER, R.H., K.R. BENWELL, H. LAMB, et al. 1999. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br. J. Pharmacol. 128: 13-20.
11. CUSSAC, D., A. NEWMAN-TANCREDI, Y. QUENTRIC, et al. 2002. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols. Naunyn Schmiedebergs Arch. Pharmacol. 365: 242-252.
12. JERMAN, J.C., S.J. BROUGH, T. GAGER, et al. 2001. Pharmacological characterisation of human 5-HT2 receptor subtypes. Eur. J. Pharmacol. 414: 23-30.
13. SCHNEIDER, B., V. MUTEL, M. PIETRI, et al. 2003. NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA 100: 13326-13331.
14. BASSANT, M.H., M. PICARD, D. OLICHON, et al. 1986. Changes in the serotonergic, noradrenergic and dopaminergic levels in the brain of scrapie-infected rats. Brain Res. 367: 360-363.
15. SAUER, H., M. WARTENBERG & J. HESCHELER. 2001. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem. 11: 173-186.
16. QUINN, M.T., T. EVANS, L.R. LOETTERLE, et al. 1993. Translocation of Rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components. J. Biol. Chem. 268: 20983-20987.
17. DUSI, S., V. DELLA BIANCA, M. GRZESKOWIAK & F. ROSSI. 1993. Relationship between phosphorylation and translocation to the plasma membrane of p47phox and p67phox and activation of the NADPH oxidase in normal and Ca(2+)-depleted human neutrophils. Biochem. J. 290(Pt 1): 173-178.
18. KAWAKAMI, N., K. KITA, T. HAYAKAWA, et al. 2000. Phorbol myristate acetate induces NADPH oxidase activity of cytochalasin B-primed neutrophils through the protein kinase C-independent pathway. Biol. Pharm. Bull. 23: 1100-1104.
19. DANA, R., T.L. LETO, H.L. MALECH & R. LEVY. 1998. Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase. J. Biol. Chem. 273: 441-445.
20. SELLMAYER, A., H. OBERMEIER, U. DANESCH, et al. 1996. Arachidonic acid increases activation of NADPH oxidase in monocytic U937 cells by accelerated translocation of p47-phox and co-stimulation of protein kinase C. Cell Signal. 8: 397-402.
21. KAMATA, H. & H. HIRATA. 1999. Redox regulation of cellular signalling. Cell Signal. 11: 1-14.
22. THANNICKAL, V.J. & B.L. FANBURG. 2000. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 279: L1005-L1028.
23. ZHANG, Z., P. OLIVER, J.J. LANCASTER, et al. 2001. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 15: 303-305.
24. DUFFY, M.J., D.J. LYNN, A.T. LLOYD & C.M. O'SHEA. 2003. The ADAMs family of proteins: from basic studies to potential clinical applications. Thromb. Haemost. 89: 622-631.
25. BLACK, R.A. 2002. Tumor necrosis factor-alpha converting enzyme. Int. J. Biochem. Cell. Biol. 34: 1-5.
26. DAWS, L.C., G.G. GOULD, S.D. TEICHER, et al. 2000. 5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. J. Neurochem. 75: 2113-2122.
27. PINEYRO, G. & P. BLIER. 1999. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 51: 533-591.
28. CHOI, D.S. & L. MAROTEAUX. 1996. Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain. FEBS Lett. 391: 45-51.
29. DUXON, M.S., T.P. FLANIGAN, A.C. REAVLEY, et al. 1997. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience 76: 323-329.
30. VOLGIN, D.V., M. MACKIEWICZ & L. KUBIN. 2001. Alpha(1B) receptors are the main postsynaptic mediators of adrenergic excitation in brainstem motoneurons, a single-cell RT-PCR study. J. Chem. Neuroanat. 22: 157-166.
31. OSBORNE, P.B., M. VIDOVIC, B. CHIENG, et al. 2002. Expression of mRNA and functional alpha(1)-adrenoceptors that suppress the GIRK conductance in adult rat locus coeruleus neurons. Br. J. Pharmacol. 135: 226-232.
32. LORIC, S., L. MAROTEAUX, O. KELLERMANN & J.M. LAUNAY. 1995. Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation. Mol. Pharmacol. 47: 458-466.
33. VILHARDT, F. & B. VAN DEURS. 2004. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J. 23: 739-748.
34. MOUILLET-RICHARD, S., M. PIETRI, B. SCHNEIDER, et al. 2005. Modulation of serotonergic receptor signaling and cross-talk by prion protein. J. Biol. Chem. 280: 4592-4601.
35. BENNA, J.E., P.M. DANG, M. GAUDRY, et al. 1997. Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation. Regulation by protein kinase C-dependent and independent pathways. J. Biol. Chem. 272: 17204-17208.
36. HAYLEY, S., K. BREBNER, S. LACOSTA, et al. 1999. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J. Neurosci. 19: 5654-5665.
37. IGNATOWSKI, T.A., B.K. NOBLE, J.R. WRIGHT, et al. 1997. Neuronal-associated tumor necrosis factor (TNF alpha): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. J. Neuroimmunol. 79: 84-90.
38. BAUD, V. & M. KARIN. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11: 372-377.
39. MACEWAN, D.J. 2002. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal. 14: 477-492.
40. MATTSON, M.P. & M. SHERMAN. 2003. Perturbed signal transduction in neurodegenerative disorders involving aberrant protein aggregation. Neuromol. Med. 4: 109-132.
41. BARNHAM, K.J., C.L. MASTERS & A.I. BUSH. 2004. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3: 205-214.
42. ANDERSEN, J.K. 2004. Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10(Suppl): S18-S25.
43. KORDEK, R., V.R. NERURKAR, P.P. LIBERSKI, et al. 1996. Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc. Natl. Acad. Sci. USA 93: 9754-9758.
44. WILLIAMS, A., A.M. VAN DAM, D. RITCHIE, et al. 1997. Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res. 754: 171-180.
45. VIVIANI, B., S. BARTESAGHI, E. CORSINI, et al. 2004. Cytokines role in neurodegenerative events. Toxicol. Lett. 149: 85-89.
46. MHATRE, M., R.A. FLOYD & K. HENSLEY. 2004. Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. J. Alzheimer's Dis. 6(2): 147-157.
47. GOTTFRIES, C.G. 1990. Neurochemical aspects on aging and diseases with cognitive impairment. J. Neurosci. Res. 27: 541-547.